Tranexamic Acid News and Research

RSS
Tranexamic acid effective for patients with head injury

Tranexamic acid effective for patients with head injury

Study measures cost-effectiveness of trauma drug published in PLoS One

Study measures cost-effectiveness of trauma drug published in PLoS One

'Consent rituals' cause life-threatening delays

'Consent rituals' cause life-threatening delays

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros receives exclusive license for new series of antifibrinolytic agents

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

ENDOMETRIN Vaginal Insert offers effective luteal support in IVF procedures

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Early administration of TXA reduces death from bleeding without increase in complications: Study

Early administration of TXA reduces death from bleeding without increase in complications: Study

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

University of Granada scientists create artificial human skin with dermis made of fibrin-agarose biomaterial

University of Granada scientists create artificial human skin with dermis made of fibrin-agarose biomaterial

Artificial human skin with dermis made from fibrin-agarose biomaterial

Artificial human skin with dermis made from fibrin-agarose biomaterial

Lysteda tablets to treat menorrhagia approved by the FDA

Lysteda tablets to treat menorrhagia approved by the FDA

FDA approves Lysteda for treating menorrhagia

FDA approves Lysteda for treating menorrhagia

Risk of death may be higher with aprotinin commonly used during cardiac surgery

Risk of death may be higher with aprotinin commonly used during cardiac surgery

Anti-fibrinolytics reduce blood loss during cardiac surgery

Anti-fibrinolytics reduce blood loss during cardiac surgery

Fibrin may be new target for Alzheimer's drugs

Fibrin may be new target for Alzheimer's drugs

Aprotinin use associated with an increased risk of death following CABG surgery

Aprotinin use associated with an increased risk of death following CABG surgery